ValorQ4, 24Q1, 25Q2, 25Q3, 25TTMGastos comerciales, generales y administrativos99.8 M105.94 M107.5 M98.5 M411.74 MInvestigación y desarrollo6.31 M5.13 M4.56 M3.8 M19.8 MBeneficio operativo-611.18 M-16.09 M-5.38 M3.3 M-629.35 MTotal de ingresos no operativos-20.02 M59.9 M-14.99 M17 M41.9 MGastos por intereses, netos de intereses capitalizados72.26 M16.98 M15.33 M43.7 M148.27 MIngresos no operativos, una vez deducidos los gastos por intereses-88.75 M43.88 M-29.59 M-29.8 M-104.25 MIngresos/gastos extraordinarios-3.53 M-967 K-731 K3.1 M-2.13 MBeneficio antes de impuestos-631.2 M43.81 M-20.36 M20.3 M-587.46 MParticipación en los beneficios—————Impuestos-19.01 M7.47 M-4.44 M3.3 M-12.68 MParticipación minoritaria—————Otros ingresos/gastos después de impuestos2.55 M382 K45 K——Beneficio neto antes de actividades interrumpidas-612.2 M36.34 M-15.92 M17 M-574.78 MOperaciones suspendidas—————Beneficio neto-612.2 M36.34 M-15.92 M17 M-574.78 MAjuste por dilución—————Dividendos de las acciones preferentes—————Beneficio neto diluido atribuible a los accionistas-612.2 M36.34 M-15.92 M17 M-574.78 MBeneficio básico por acción-2.820.17-0.07-0.08-2.8Beneficio por acción diluido-2.820.17-0.07-0.08-2.8Número medio de acciones ordinarias216.89 M217.22 M217.41 M217.4 M868.92 MAcciones diluidas216.89 M217.33 M217.41 M217.9 M869.54 MEBITDA-580.92 M12.96 M23.55 M——EBIT-611.18 M-16.09 M-5.38 M-3.3 M-635.95 MCosto de los ingresos132.6 M114.22 M118.01 M112.2 M477.03 MOtros costes de producción—————Amortización y depreciación (flujo de caja)30.26 M29.05 M28.93 M——
Neogen Corporation
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues.